Searchable abstracts of presentations at key conferences in endocrinology

ea0034p87 | Clinical practice/governance and case reports | SFEBES2014

Look before you leap… An adrenal mass and elevated metadrenalines may not be phaeochromocytoma

Galloway Iona , McAulay Vincent , Ferguson Stewart

A 73-year-old female with previous tuberculosis, primary hypothyroidism, depression and caecal cancer was referred to Endocrinology when interval CT scanning reported a 2.5 cm adrenal mass, stable in size over 4 years. No symptoms or signs of hormonal production were noted. Screening tests were abnormal: post-1 mg dexamethasone cortisol was 98 nmol/l, 24-h urinary free metadrenaline was elevated tenfold (3256 nmol/24 h, range 0–350) to a concentration reported to have hig...

ea0062wh9 | Workshop H: Miscellaneous endocrine and metabolic disorders | EU2019

A challenging case of chronic hyponatraemia

Galloway Iona , Garrahy Aoife , Sherlock Mark , Thompson Christopher

A 56-year-old male presented in 2017 with acute symptomatic hyponatraemia. He was admitted with a seizure and a plasma sodium of 112 mmol/l. His past medical history was notable for alcohol excess and smoking. The acute presentation was managed with 3% hypertonic saline infusion in ITU. Plasma osmolality was 240 mOsm/Kg, urine osmolality 327 mOsm/kg and sport urine sodium 28 mmol/l. CT TAP showed some oesophageal thickening only; endoscopy was normal. He made a good recovery f...

ea0059ep22 | Bone and calcium | SFEBES2018

Fibroblast Growth Factor 23 (FGF23) is a useful biomarker in the investigation of incidental hypophosphataemia

Connelly Paul , Galloway Iona , Gallacher Stephen , Gallagher Andrew

A 77 year old female was referred to endocrinology with an incidental finding of hypophosphataemia (0.26 mmol/l) on routine bloods. She described a slight unsteadiness on her feet, but denied bone pain or overt muscle weakness. Past medical history included Type 2 Diabetes Mellitus, a left humeral fragility fracture and the subsequent diagnosis of osteoporosis 2 years previously. At presentation the corrected calcium was slightly elevated (2.64 mmol/l), which normalised when r...

ea0063p695 | Pituitary and Neuroendocrinology 2 | ECE2019

Severe salt wasting syndrome due to spontaneous epidural haematoma

Garrrahy Aoife , Hakami Osamah , Galloway Iona , McNally Stephen , Dwyer Rory , Thompson Christopher J , Sherlock Mark

Hyponatraemia is commonly encountered in neurosurgical units. Salt wasting syndrome is rare, and thought to occur due to ANP- and BNP-mediated natriuresis, leading to hypovolemic hyponatraemia. A 31 year old male was transferred to the National Neurosurgical Unit with a 12 hour history of back pain, progressive lower limb weakness and sensory loss. MRI demonstrated an epidural haematoma, extending from C7 to T3, and he underwent emergency decompressive laminectomy. Vasopressin...

ea0059p021 | Adrenal and steroids | SFEBES2018

Does a 60 minute sample in addition to a 30 minute sample for cortisol in the Short Synacthen Test alter patient management?

Campbell Karen , Galloway Iona , Grant Donna , Smith Frances , Tough Jillian , Freel E Marie

Aim: The short Synacthen test (SST) is an established test used to assess the hypothalamic-pituitary-adrenal axis. There remains debate whether a 30 minute or 60 minute cortisol sample has diagnostic superiority. Currently at the Queen Elizabeth University Hospital, Glasgow all tests arranged by endocrinology are performed by endocrine nurse specialists who utilise a 0 and 30 minute cortisol protocol. Performing a further 60 minute sample requires more nursing time and space r...

ea0070oc4.7 | Pituitary and Neuroendocrinology | ECE2020

Fluid restriction results in a modest rise in plasma sodium concentration in chronic hyponatraemia due to SIAD; results of a prospective randomised controlled trial

Garrahy Aoife , Galloway Iona , Hannon Anne Marie , Dineen Rosemary , O’Kelly Patrick , Tormey William , O’Reilly Michael , Williams David , Sherlock Mark , Thompson Chris

Fluid restriction (FR) is the recommended first-line treatment for chronic hyponatraemia due to syndrome of inappropriate antidiuresis (SIAD) in expert guidelines, despite the lack of prospective data to support its efficacy. We aimed to test the hypothesis that FR was more effective than no treatment. 46 patients with chronic SIAD were randomised to either fluid restriction (1 litre/day, FR) or no specific hyponatraemia treatment (NoTx) for one month. Inclusion criteria were ...